The company was founded in 2004 as spin-off of the Technical University of Darmstadt to develop products with the new and patented chemical entity diperoxochloric acid for the treatment of chronic wounds. A diperoxochloric acid based medicinal product is marketed since 2020/21 as WOXHeal in India for the treatment of Diabetic Foot Ulcer (DFU) under licence by Centaur. A DPOCl-based medical device for DFU is currently under development for the European and US market.